Saturday, September 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document

The Download: “reprogramming” aging, and the hidden sense of interoception

View original at technologyreview.com
MIT Technology Review - Ai Research Title: The Download: “reprogramming” aging, and the hidden sense of interoception Date: 2026-06-12 12:10 Source: https://www.technologyreview.com/2026/06/12/1138899/the-download-reprogramming-reverse-aging-interoception/ <p><em>This is today’s edition of </em><a href="https://forms.t…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • If the glaucoma reprogramming treatment succeeds, similar treatments could reverse other diseases of aging and potentially aging altogether.

    60% confidence
  • SpaceX's IPO is overvalued; investors are paying for Elon Musk's personal brand rather than the company's fundamentals.

    60% confidence
  • Orbital data centers are harder to build than Silicon Valley estimates because shedding heat in space requires ingenious new designs.

    60% confidence
  • Cell reprogramming is the buzziest and most rapidly accelerating approach to reversing aging among the many strategies being explored by biotech companies.

    60% confidence
  • Interoception research is taking off thanks to a 2021 Nobel Prize and new tools that can map internal signaling across the body, with implications for treating obesity, chronic pain, and anxiety.

    60% confidence
  • AI systems will unify into a single battlefield network, creating a 'new paradigm' of warfare.

    60% confidence
  • Chinese cybercriminals used Google's Gemini AI to power scam operations targeting Americans.

    60% confidence

Data points we hold from this source

SpaceX · ipo raise75 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com
The Download: “reprogramming” aging, and the hidden sense of interoception — Source | Via News | Via News